Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

Sex-Specific Role for Dopamine Receptor D2 in Dorsal Raphe Serotonergic Neuron Modulation of Defensive Acoustic Startle and Dominance Behavior

Krissy A. Lyon, Benjamin D. Rood, Lorna Wu, Rebecca A. Senft, Lisa V. Goodrich and Susan M. Dymecki
eNeuro 19 November 2020, 7 (6) ENEURO.0202-20.2020; DOI: https://doi.org/10.1523/ENEURO.0202-20.2020
Krissy A. Lyon
1Department of Genetics, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Krissy A. Lyon
Benjamin D. Rood
1Department of Genetics, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorna Wu
2Department of Neurobiology, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca A. Senft
1Department of Genetics, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca A. Senft
Lisa V. Goodrich
2Department of Neurobiology, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa V. Goodrich
Susan M. Dymecki
1Department of Genetics, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Susan M. Dymecki
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Visualization of Drd2-Pet1 serotonergic neurons and the loss of Drd2 gene expression in Drd2Pet1-CKO mice. A, Drd2-Pet1 neurons are intersectionally labeled with GFP (green) and Pet1-only positive cell bodies labeled with mCherry (magenta) in a coronal brain section of the DR from a P90 triple transgenic Drd2-Cre;Pet1-Flpe;RC:FrePe mouse. Scale bars: 200 μm. B, Intersectional genetic strategy: expression of Drd2-Cre and Pet1-Flpe transgenes results in dual recombination of intersectional allele, RC:FrePe, labeling cells expressing Drd2 and Pet1 with GFP. C, Dual immunohistochemistry for GFP (green) and 5-HT (serotonin, magenta) coupled with FISH detection of Drd2 mRNA, which shows co-localization of intersectionally labeled Drd2-Pet1 neuron cell bodies with 5-HT and Drd2 mRNA. Scale bars: 10 μm. D, Strategy for conditional deletion of Drd2 in serotonergic neurons (referred to throughout as Drd2Pet1-CKO). Cre recombination excises Drd2 exon 2 (magenta) producing serotonergic-specific (boxed in green) deletion of Drd2 gene sequences. E, Percentage (mean ± SEM) of Pet1+ serotonergic neurons that express Drd2 in control (n = 6) versus Drd2Pet1-CKO (n = 6) shows reduction of Drd2 expression in Pet1+ neurons (controls: 15.23 ± 2.41 Drd2-Pet1 dual positive neurons per brain, Drd2Pet1-CKO: 3.87 ± 0.73 Drd2-Pet1 dual positive neurons per brain, p = 0.0011, unpaired t test). Filled black diamonds represent male mice, open gray circles represent female mice. F, G, FISH on (F) control and (G) Drd2Pet1-CKO tissue. Drd2 transcripts detected in Pet1+ cells in control sections, but not in Drd2Pet1-CKO mice, indicative of loss of Drd2. cre transcript is not present in control (F, far right) but is present in Drd2Pet1-CKO Pet1 cells, as expected (G, far right). Pet1, Drd2, and cre transcript are shown separately in grayscale. Note Drd2 expression remains in non-Pet1 cells (arrow). Dotted lines drawn to encircle DAPI nuclei. Scale bars: 25 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Drd2Pet1-CKO mice are largely behaviorally normal. Drd2Pet1-CKO (blue symbols) mice show behaviors indistinguishable from controls (black symbols) in measures of locomotion: (A, B) open field test and (C) rotarod; measures of anxiety-like and depression-like behavior: (D) elevated plus maze, (E) tail suspension test, and (F) forced swim test; or learning and memory: (G) contextual fear conditioning and (H) water T maze; n = 15 control mice (8 males, 7 females) and 11 Drd2Pet1-CKO (6 males, 5 females), except for C where, n = 21 control mice (14 males, 7 females) and 18 Drd2Pet1-CKO (13 males, 5 females). Each symbol represents one animal, error bars represent SEM. No significant differences (p > 0.05) between Drd2Pet1-CKO and controls were observed. No sex-specific (male vs female) phenotypes observed. For assay details, see Materials and Methods; for statistical details, see Table 2.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Drd2Pet1-CKO females, but not males, display attenuated acoustic startle responses (ASR). A, Schematic of ASR experimental design. After an initial 5-min acclimation, mice are exposed to 10 blocks of 11 trials of auditory stimuli ranging from 20 to 120 dB in quasi-randomized order with a 10- to 20-s intertrial interval (ITI). B, Schematic of ASR measurement apparatus, mouse is placed in a perforated holding chamber atop transducer platform adjacent to speaker (for detailed description, see Materials and Methods). C, F, Averaged ASR magnitudes (mean ± SEM) across increasing stimulus intensities in (C) male Drd2Pet1-CKO (blue, n = 13) and controls (black, n = 14), no significant difference, p = 0.7745, two-way ANOVA and (F) female Drd2Pet1-CKO (blue, n = 15) and controls (black, n = 16), Drd2Pet1-CKO females display significantly attenuated ASR, p = 0.0011, two-way ANOVA. D, G, Group averaged ASR for 10 trials at 110-dB stimulus in (D) males and (G) females, demonstrates no habituation to the startle stimulus; x-axis numbers refers to trial number out of 110 total trials. E, H, No significant differences in latency to startle are observed in (E) males, p = 0.1319, two-way ANOVA and (H) females, p = 0.5452, two-way ANOVA. I, J, No significant differences in prepulse inhibition of acoustic startle are observed in (I) males (n = 8 control, 6 Drd2Pet1-CKO), p = 0.4325, two-way ANOVA or (J) females (n = 7 control, 5 Drd2Pet1-CKO, p = 0.4380, two-way ANOVA).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Drd2Pet1-CKO mice show normal auditory responses. A, B, Average ABR waveforms at 16 kHz for (A) control (black, n = 10) and Drd2Pet1-CKO (blue, n = 7) males and (B) for control (black, n = 8) and Drd2Pet1-CKO (blue, n = 7) females. Average is shown by darker lines and shaded area shows SEM. C, F, ABR amplitudes for control (black) and Drd2Pet1-CKO (blue; C) male and (F) female mice for ABR peaks 1 through 3. No significant difference was observed between control and Drd2Pet1-CKO: males, p = 0.2032; females, p = 0.1387, two-way ANOVA. D, F, Latencies for control (black) and Drd2Pet1-CKO (blue; D) male and (G) female mice for ABR peaks 1 through 3. No significant difference was observed between control and Drd2Pet1-CKO: males, p = 0.0804; females, p = 0.9430, two-way ANOVA. Amplitudes and latencies shown at 80-dB SPL. E, H, ABR thresholds for control (black) and Drd2Pet1-CKO (blue; E) male and (H) female mice across frequencies tested (5.6, 8, 16, and 32 kHz). No significant difference was observed between control and Drd2Pet1-CKO mice, p > 0.05 at all frequencies, unpaired t test.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Drd2Pet1-CKO males, but not females, display increased social dominance. A, B, Three chambered social interaction assay. No significant difference in time spent investigating a stranger mouse or an empty holder for (A) males (n = 8 controls compared with 6 Drd2Pet1-CKO, p = 0.541, unpaired t test) and (B) females (n = 7 controls compared with n = 5 Drd2Pet1-CKO, p = 0.358, unpaired t test). Investigation time is binned into 5-min intervals where white bars indicate first 5 min of assay and colored bars indicate last 5 min of assay. As expected, mice of both genotypes spent significantly less time investigating the empty holder than the stranger mouse noting that females of both genotypes only did so during the first 5 min of the assay. C, Resident intruder assay of aggression. No significant difference in the average attack bites per day delivered to a Swiss Webster intruder mouse was observed between Drd2Pet1-CKO males (n = 26, 4.07 ± 1.50 bites) aggression levels were not significantly different from controls (n = 24, 1.77 ± 0.39 bites; Mann–Whitney, two-tailed, U = 289.5, p = 0.6649). D, Schematic of tube test (for details of assay, see Materials and Methods). Schematic created with BioRender. E, Drd2Pet1-CKO males (n = 24) demonstrate more dominance behavior than controls (n = 24) as they displayed increased winning in the tube test (controls: 34.17 ± 9% wins, Drd2Pet1-CKO: 65.83 ± 9% wins, p = 0.0065, Mann–Whitney, two-tailed, U = 166). Female Drd2Pet1-CKO (n = 23) showed no difference in social dominance compared with controls (n = 23; controls: 51.3 ± 8%, Drd2Pet1-CKO: 48.7 ± 8% wins, p = 0.8123 Mann–Whitney, two-tailed, U = 253).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Sex-specific transcript level differences in Drd2-Pet1 neurons. A, Dual immunohistochemistry and FISH depicting green GFP+ Drd2-Pet1 neurons along with transcript puncta in male (top) and female (bottom) brain sections from Drd2-Cre;Pet1-Flpe;RC-FrePe mice. Drd2 (cyan) and Gad2 (magenta) expression shown together and separately in gray scale. Scale bar: 10 μm. B, Number of Drd2-Pet1 neurons (GFP-positive cells in Drd2-Cre;Pet1-Flpe;RC-FrePE mice) per animal in males (black diamonds, n = 7) and females (open gray circles, n = 7) is not significantly different. Males: 410.40 ± 55.30 cells/brain, females: 313 ± 87.52 cells/brain, p = 0.4336, unpaired t test. C, Drd2-Pet1 neuron soma size (GFP+ cell body) does not differ in males (n = 5 males) versus females (n = 5 females), p = 0.3372, unpaired t test. D, Number of FISH mRNA puncta per cell in males versus females. Male cells have significantly more Gad2 puncta than female cells [20.46 ± 2.243 in males (n = 5) vs 12.20 ± 2.427 in females (n = 5), p = 0.0370, unpaired t test]. E, 86.47 ± 4.181% of male Drd2-Pet1 cells express Gad2 versus female 74.00 ± 5.168% in female cells, p = 0.0975, unpaired t test. Error bars indicate SEM throughout. For C, D, larger symbols outlined in black represent animal averages used for statistical analysis, smaller symbols represent individual cells, matched in color to the average.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Gad2 expression in Drd2Pet1-CKO cells. A, FISH with probes to Drd2 exon 7/8 (D2-E7/8, green) and Drd2 exon 2 (D2-E2, magenta) in Pet1 (white) cells in control (top) and Drd2Pet1-CKO (bottom) DR tissue. D2-E7/8, D2-E2, and Pet1 expression shown together and separately in gray scale. B, Percent of Pet1+ cells (left and middle) with Drd2-Exon7/8 expression in control (35.97 ± 2.403%, n = 6) and Drd2Pet1-CKO (36.53 ± 3.621%, n = 6), p = 0.8998, unpaired t test. Data also shown for percent of cre cells (right) with Drd2-Exon7/8, 34.91 ± 2.238%, compared with Pet1 probe control and Drd2Pet1-CKO p = 0.9051, one-way ANOVA. Males, black diamonds, females, open gray circles. C, FISH showing cre+ Drd2Pet1-CKO cells (white) with Drd2-Exon7/8 (green) and Gad2 (red) in male (top) and female (bottom) in the DR nucleus. Drd2-Exon7/8, Gad2, and cre are shown together and separately in gray scale. Scale bar: 10 μm. D, A larger percentage of male Drd2Pet1-CKO cells (87.44 ± 3.034%) express Gad2 versus female Drd2Pet1-CKO cells (75.76 ± 0.5862%), *p = 0.0157, unpaired t test. E, Number of Gad2 mRNA puncta per cell in Drd2Pet1-CKO cells in males (n = 6) versus females (n = 4). Male cells have 14.25 ± 1.325 Gad2 puncta per cell compared with 10.13 ± 2.074 in female cells, p = 0.1151, unpaired t test. F, Drd2Pet1-CKO nucleus size (area used to quantify puncta levels) does not differ in males (n = 6 males) versus females (n = 4 females), p = 0.3497, unpaired t test. Error bars indicate SEM throughout. For E, F, larger symbols outlined in black represent animal averages used for statistical analysis, smaller symbols represent individual cells, matched in color to the average.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Drd2-Pet1 neuron electrophysiological properties in male versus female mice. Membrane and AP characteristics were analyzed in GFP-marked Drd2-Pet1 male and female neurons using whole-cell patch-clamp electrophysiology in acute brain slices from triple transgenic Drd2-Cre;Pet1-Flpe;RC-FrePe mice. Membrane potential (A), membrane resistance (B), AP threshold (C), AP amplitude (D), and AHP amplitude (F) do not differ in male (n = 19) or female (n = 44) Drd2-Pet1 neurons while (E) male Drd2-Pet1 neurons had a significantly longer (2.847 ± 0.155 ms, n = 19 cells) AP duration than in females (2.54 ± 0.094 ms, n = 44 cells, p = 0.0275, unpaired t test).

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Drd2-Pet1 neuron axon terminals target brain regions involved in sensory processing and defensive behavior in both male and female mice. A, Intersectional genetic strategy: expression of Drd2-Cre and Pet1-Flpe transgenes results in dual recombination of intersectional allele, RC-FPSit, to label boutons of Drd2-Pet1 neurons with Synaptophysin-GFP. B, Representative images of Drd2-Pet1 boutons in the SOC and IC. GFP+ (green, marked with arrows) boutons co-localize with 5-HT (magenta) staining. DAPI-stained nuclei shown in blue. Scale bar: 25 μm. C, Quantification of the percent target area occupied by projections for all ten brain regions examined (for quantification protocol, see Materials and Methods). Target areas analyzed include brain regions involved in auditory processing and social behavior including the CNC, SOC, LL, IC, PNC, mHb, dLGN, mPOA, and PAG. The DPGi was also examined. No significant differences in projection area innervation were observed between males (n = 5) and females (n = 6). D, Example graph showing correlation between innervation density of auditory brain regions differs in males compared with females. Each dot represents one animal. Values are shown as Pearson’s correlation coefficient (r), and * indicates p < 0.5 in a two-tailed test. E, Pairwise correlations shown for male and female innervation density in auditory brain regions. Heatmaps represent high correlation (green) and low correlation (black) between CNC, SOC, LL, IC, and PNC.

  • Figure 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 10.

    GABA immunoreactivity localizes to soma, but not axonal projections, of Drd2-Pet1 neurons. A, GABA staining (magenta) co-localizes with many Drd2-Pet1 neuron soma (green GFP-positive cell bodies in Drd2-Cre;Pet1-Flpe;RC-FPSit mice) in the DR in a punctate manner (top), inset of boxed region showing neuron soma positive for GFP and GABA. Some Drd2-Pet1 neuron soma are immuno-negative for GABA (bottom). Dotted lines encircle GFP-positive cell body. B, C, No GFP-positive Drd2-Pet1 boutons (green) co-localize with GABA staining (magenta) in brain regions examined, shown here, representative images from SOC (B) and IC (C), noting a GABA-positive soma is visible in the image of the IC. D, GABA-positive immunoreactivity in the corpus callosum demonstrating detection of GABA boutons. ChAT (white) staining was used throughout for anatomic localization. Scale bars: 25 μm (left panel) and 10 μm (inset). DAPI-stained nuclei shown in blue.

Tables

  • Figures
    • View popup
    Table 1

    Settings for Gad2 quantification in Drd2Pet1-CKO tissue

    ProbeS1S2ProminenceR2RMSEMAE
    E20.2511750.86960.59570.2458
    E7/80.511000.94210.80540.35
    Cre0.511000.96793.8292.2244
    Fev0.252750.95554.4143.7047
    Gad20.25161500.85682.8041.7973
    • Summary of settings and performance in a linear regression for semi-automated protocol versus hand counts for each FISH probe.

    • View popup
    Table 2

    Statistical analysis

    Behavior/experimentLineData structure
    (normality)
    Type of testPower
    ComparisonF/dfp
    Validation of Drd2 CKO1EYesUnpaired t testControl vs Drd2Pet1-CKOt = 4.514, df = 10p = 0.0011
    Open field distance2AYesRepeated-measures ANOVAF1, genotypeF(1,24) = 0.6405p = 0.4314
    F2, timeF(11,264) = 47.99p < 0.0001
    (F1 × F2)F(11,264) = 0.8441p = 0.5960
    Open field % distance traveled2BYesUnpaired t testControl vs Drd2Pet1-CKOt = 1.781, df = 24p = 0.0876
    Rotarod2CNoMann–Whitney, two-tailedControl vs Drd2Pet1-CKOM–W U = 142p = 0.1899
    Elevated plus maze (% time in open arm)2DYesUnpaired t testControl vs Drd2Pet1-CKOt = 1.250, df = 24p = 0.2234
    Tail suspension test2EYesUnpaired t testControl vs Drd2Pet1-CKOt = 0.3485, df = 24p = 0.7305
    Forced swim test2FYesRepeated-measures ANOVAF1, genotypeF(1,24) = 0.2678p = 0.6095
    F2, timeF(5,120) = 8.916p < 0.0001
    (F1 × F2)F(5,120) = 0.3090p = 0.9067
    Contextual fear conditioning (baseline freezing)2GYesUnpaired t testControl vs Drd2Pet1-CKOt = 0.6682, df = 24p = 0.5104
    Contextual fear conditioning (test freezing)Unpaired t testControl vs Drd2Pet1-CKOt = 0.0127, df = 24p = 0.9900
    Water T maze (%correct during acquisition)2HYesRepeated-measures ANOVAF1, genotypeF(1,24) = 0.08249p = 0.7764
    F2, timeF(4,89) = 50.12p < 0.0001
    (F1 × F2)F(4,89) = 0.6698p = 0.6147
    Water T maze (%correct during reversal)YesRepeated-measures ANOVAF1, genotypeF(1,24) = 0.1631p = 0.6899
    F2, timeF(4,96) = 172.4p < 0.0001
    (F1 × F2)F(4,96) = 1.477p = 0.2153
    ASR (M)3CYesRepeated-measures ANOVAF1, genotypeF(1,25) = 0.0840p = 0.7745
    F2, dBF(10,250) = 28.99p < 0.0001
    (F1 × F2)F(10,250) = 0.3037p = 0.9798
    ASR habituation (M)3DYesPearson r correlationControl trial number × startle responser = −0.195p = 0.5893
    Drd2Pet1-CKO trial number × startle responser = 0.136p = 0.7079
    ASR latency (M)3EYesRepeated-measures ANOVAF1, genotypeF(1,25) = 2.425p = 0.1319
    F2, dBF(10,250) = 21.67p < 0.0001
    (F1 × F2)F(10,250) = 0.4722p = 0.9071
    ASR (F)3FYesRepeated-measures ANOVAF1, genotypeF(1,29) = 13.26p = 0.0011
    F2, dBF(10,29) = 35.29p < 0.0001
    (F1 × F2)F(10,290) = 7.475p < 0.0001
    ASR habituation (F)3GYesPearson r correlationControl trial number × startle responser = 0.1171p = 0.7473
    Drd2Pet1-CKO trial number × startle responser = 0.05165p = 0.8873
    ASR latency (F)3HYesRepeated-measures ANOVAF1, genotypeF(1,29) = 0.3748p = 0.5452
    F2, dBF(10,290) = 20.59p < 0.0001
    (F1 × F2)F(10,290) = 1.058p = 0.3953
    PPI (M)3IYesRepeated-measures ANOVAF1, genotypeF(1,12) = 0.6625p = 0.4315
    F2, prepulse dBF(2,24) = 42.86p < 0.0001
    (F1 × F2)F(2,24) = 4.104p = 0.0293
    PPI (F)3JYesRepeated-measures ANOVAF1, genotypeF(1,10) = 0.6526p = 0.4380
    F2, prepulse dBF(2,20) = 31.34p < 0.0001
    (F1 × F2)F(2,20) = 1.609p = 0.2249
    ABR amplitude (M)4CYesRepeated-measures ANOVAF1, genotypeF(1,15) = 1.770p = 0.2032
    F2, peakF(2,30) = 59.09p < 0.0001
    (F1 × F2)F(2,30) = 1.059p = 0.3595
    ABR latency (M)4DYesRepeated-measures ANOVAF1, genotypeF(1,15) = 3.515p = 0.0804
    F2, peakF(2,30) = 1171p < 0.0001
    (F1 × F2)F(2,30) = 3.121p = 0.0587
    ABR threshold (M)4E     
    5.6YesUnpaired t testControl vs Drd2Pet1-CKOt = 0.9535, df = 14p = 0.3565
    8YesUnpaired t testControl vs Drd2Pet1-CKOt = 1.894, df = 14p = 0.0791
    16YesUnpaired t testControl vs Drd2Pet1-CKOt = 1.103, df = 14p = 0.2887
    32YesUnpaired t testControl vs Drd2Pet1-CKOt = 2.129, df = 7p = 0.0708
    ABR amplitude (F)4FYesRepeated-measures ANOVAF1, genotypeF(1,13) = 2.489p = 0.1387
    F2, peakF(2,26) = 72.52p < 0.0001
    (F1 × F2)F(2,26) = 0.0487p = 0.9525
    ABR latency (F)4GYesRepeated-measures ANOVAF1, genotypeF(1,13) = 0.0053p = 0.9430
    F2, peakF(2,26) = 4360p < 0.0001
    (F1 × F2)F(2,26) = 0.0822p = 0.9213
    ABR threshold (F)4H     
    5.6YesUnpaired t testControl vs Drd2Pet1-CKOt = 0.1566, df = 13p = 0.8770
    8YesUnpaired t testControl vs Drd2Pet1-CKOt = 0.1592, df = 14p = 0.8757
    16YesUnpaired t testControl vs Drd2Pet1-CKOt = 0.9600, df = 14p = 0.3533
    32YesUnpaired t testControl vs Drd2Pet1-CKOt = 1.644, df = 9p = 0.1346
    Social interaction (M, %time with stranger)5AYesUnpaired t testControl vs Drd2Pet1-CKOt = 0.6283, df = 12p = 0.5415
    Social interaction (F, %time with stranger)5BYesUnpaired t testControl vs Drd2Pet1-CKOt = 0.9598, df = 10p = 0.3598
    Resident-intruder assay5CNoMann–Whitney, two-tailedControl vs Drd2Pet1-CKOM–W U = 289.5p = 0.6649
    Tube test of social dominance5E     
    Male NoMann–Whitney, two-tailedControl vs Drd2Pet1-CKOM–W U = 166p = 0.0065
    Female NoMann–Whitney, two-tailedControl vs Drd2Pet1-CKOM–W U = 253p = 0.8123
    Drd2-Pet1 neuron count6AYesUnpaired t testMale vs femalet = 0.8160, df = 12p = 0.4304
    Soma size6CYesUnpaired t testMale vs femalet = 1.021, df = 8p = 0.3372
    Gene expression6D     
    DmdYesUnpaired t testMale vs femalet = 0.9581, df = 7p = 0.3699
    Drd2YesUnpaired t testMale vs femalet = 1.514, df = 8p = 0.1686
    Gad2YesUnpaired t testMale vs femalet = 2.498, df = 8p = 0.0370
    Serpini1YesUnpaired t testMale vs femalet = 1.459, df = 7p = 0.1879
    %Gad2+ Drd2-Pet1 neurons6EYesUnpaired t testMale vs femalet = 1.876, df = 8p = 0.0975
    % Drd2-Exon7/8+7BYesUnpaired t testControl vs Drd2Pet1-CKO with Pet1 probet = 0.1291, df = 10p = 0.8998
    YesOne-way ANOVAControl/Pet1 probe vs Drd2Pet1-CKO/
    Pet1 probe vs Drd2Pet1-CKO /Cre probe
    F(2,19) = 0.1003p = 0.9051
    % Gad2 in Cre+ neurons7DYesUnpaired t testMale vs femalet = 3.057, df = 8p = 0.0157
    Gad2 punctae per cell7EYesUnpaired t testMale vs femalet = 1.768, df = 8p = 0.1151
    Nucleus area7FYesUnpaired t testMale vs femalet = 0.9931, df = 8p = 0.3497
    Resting membrane potential8AYesUnpaired t testMale vs femalet = 0.2113, df = 61p = 0.8334
    Membrane resistance8BYesUnpaired t testMale vs femalet = −0.4084, df = 61p = 0.6844
    AP threshold8BYesUnpaired t testMale vs femalet = 1.8197, df = 61p = 0.0737
    AP amplitude8DYesUnpaired t testMale vs femalet = −1.0474, df = 61p = 0.2990
    AP duration8EYesUnpaired t testMale vs femalet = −2.2583, df = 61p = 0.0275
    AHP amplitude8FYesUnpaired t testMale vs femalet = 1.350, df = 61p = 0.1821
    Innervation densities9C     
    DPGiYesUnpaired t testMale vs femalet = 1.285, df = 9p = 0.2308
    PAGYesUnpaired t testMale vs femalet = 0.2398, df = 9p = 0.8158
    mPOAYesUnpaired t testMale vs femalet = 0.1978, df = 9p = 0.8476
    DLGYesUnpaired t testMale vs femalet = 0.07798, df = 9p = 0.9395
    mHbYesUnpaired t testMale vs femalet = 0.6732, df = 9p = 0.5178
    PnCYesUnpaired t testMale vs femalet = 0.7901, df = 9p = 0.4498
    ICYesUnpaired t testMale vs femalet = 0.5350, df = 9p = 0.6056
    LLYesUnpaired t testMale vs femalet = 0.9100, df = 9p = 0.3865
    SOCYesUnpaired t testMale vs femalet = 0.9282, df = 9p = 0.3775
    CNCYesUnpaired t testMale vs femalet = 0.2997, df = 9p = 0.7712
    • Statistical values are provided for behavioral analyses of Drd2Pet1-CKO mice and comparison of Drd2-Pet1 neuron properties in male versus female mice. Figure numbers are included to reference corresponding graphs. Statistical analyses were conducted in GraphPad Prism version 8.1.

Back to top

In this issue

eneuro: 7 (6)
eNeuro
Vol. 7, Issue 6
November/December 2020
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sex-Specific Role for Dopamine Receptor D2 in Dorsal Raphe Serotonergic Neuron Modulation of Defensive Acoustic Startle and Dominance Behavior
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Sex-Specific Role for Dopamine Receptor D2 in Dorsal Raphe Serotonergic Neuron Modulation of Defensive Acoustic Startle and Dominance Behavior
Krissy A. Lyon, Benjamin D. Rood, Lorna Wu, Rebecca A. Senft, Lisa V. Goodrich, Susan M. Dymecki
eNeuro 19 November 2020, 7 (6) ENEURO.0202-20.2020; DOI: 10.1523/ENEURO.0202-20.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Sex-Specific Role for Dopamine Receptor D2 in Dorsal Raphe Serotonergic Neuron Modulation of Defensive Acoustic Startle and Dominance Behavior
Krissy A. Lyon, Benjamin D. Rood, Lorna Wu, Rebecca A. Senft, Lisa V. Goodrich, Susan M. Dymecki
eNeuro 19 November 2020, 7 (6) ENEURO.0202-20.2020; DOI: 10.1523/ENEURO.0202-20.2020
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • acoustic startle
  • dominance
  • dopamine receptor
  • raphe
  • serotonin
  • sex differences

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Brain Activation and Functional Connectivity of Reappraisal and Acceptance for Anxious Events
  • β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats
  • Running throughout Middle-Age Keeps Old Adult-Born Neurons Wired
Show more Research Article: New Research

Cognition and Behavior

  • Neuronal representation of a working memory-based decision strategy in the motor and prefrontal cortico-basal ganglia loops
  • Strawberry additive increases nicotine vapor sampling and systemic exposure but does not enhance Pavlovian-based nicotine reward in mice
  • Attention Without Constraint: Alpha Lateralization in Uncued Willed Attention
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.